Selective improvement in renal function preserved remote myocardial microvascular integrity and architecture in experimental renovascular disease

Atherosclerosis

Volumn 221, Issue 2, 2012, Pages 350-358

  Urbieta Caceres, Victor H ^a   Zhu, Xiang Yang ^a   Jordan, Kyra L ^a   Tang, Hui ^a   Textor, Kyle ^a   Lerman, Amir ^a   Lerman, Lilach O ^a  

^a MAYO CLINIC   (United States)

Author keywords

Atherosclerosis; Inflammation; Microcirculation

Indexed keywords

ALDOSTERONE; CREATININE; ENDOTHELIN 1; INTERLEUKIN 6; ISOPROSTANE; OXIDIZED LOW DENSITY LIPOPROTEIN; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA; URIC ACID;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ATHEROSCLEROSIS; ATHEROSCLEROTIC RENOVASCULAR DISEASE; BLOOD PRESSURE; BLOOD PRESSURE MEASUREMENT; BLOOD SAMPLING; CARDIOVASCULAR FUNCTION; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; DENSITY; DIASTOLIC BLOOD PRESSURE; DISEASE SEVERITY; ENDOTHELIUM CELL; EXPERIMENTAL STUDY; FIBROGENESIS; GLOMERULUS FILTRATION RATE; HEART DISEASE; HEART FUNCTION; HEART MUSCLE; HEART MUSCLE FIBROSIS; HEART OUTPUT; HEART VENTRICLE HYPERTROPHY; HYPERCHOLESTEROLEMIA; INFLAMMATION; KIDNEY ARTERY STENOSIS; KIDNEY BLOOD FLOW; KIDNEY FUNCTION; KIDNEY INJURY; KIDNEY VEIN; MEAN ARTERIAL PRESSURE; MEMBRANE PERMEABILITY; MICRO-COMPUTED TOMOGRAPHY; MICROVASCULATURE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RENOVASCULAR DISEASE; RENOVASCULAR HYPERTENSION; SIGNAL TRANSDUCTION; STEM CELL; SWINE; SYSTEMIC CIRCULATION; SYSTOLIC BLOOD PRESSURE;

ANIMALS; ATHEROSCLEROSIS; BALLOON DILATION; BIOLOGICAL MARKERS; BLOOD PRESSURE; CAPILLARY PERMEABILITY; CARDIAC OUTPUT; CELLS, CULTURED; CORONARY CIRCULATION; DIET, HIGH-FAT; DISEASE MODELS, ANIMAL; ENDOTHELIAL CELLS; FIBROSIS; GLOMERULAR FILTRATION RATE; HEART DISEASES; HYPERCHOLESTEROLEMIA; HYPERTENSION, RENOVASCULAR; INFLAMMATION MEDIATORS; KIDNEY; MICROCIRCULATION; MICROVESSELS; OXIDATIVE STRESS; RENAL ARTERY OBSTRUCTION; STEM CELL TRANSPLANTATION; STROKE VOLUME; SUS SCROFA; TIME FACTORS; X-RAY MICROTOMOGRAPHY;

EID: 84862793020     PISSN: 00219150     EISSN: 18791484     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2011.10.005     Document Type: Article

References (42)

1. Coresh J., Selvin E., Stevens L.A., et al. Prevalence of chronic kidney disease in the United States. JAMA 2007, 298:2038-2047.
2. James M.T.H.B., Tonelli M. Early recognition and prevention of chronic kidney disease. Lancet 2010, 1296-1309.
3. Culleton B.F., Larson M.G., Wilson P.W., Evans J.C., Parfrey P.S., Levy D. Cardiovascular disease and mortality in a community-based cohort with mild renal insufficiency. Kidney International 1999, 56:2214-2219.
4. Go A.S., Chertow G.M., Fan D., McCulloch C.E., Hsu C.Y. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. The New England Journal of Medicine 2004, 351:1296-1305.
5. Edwards M.S., Craven T.E., Burke G.L., Dean R.H., Hansen K.J. Renovascular disease and the risk of adverse coronary events in the elderly: a prospective, population-based study. Archives of Internal Medicine 2005, 165:207-213.
6. Shlipak M.G., Fried L.F., Crump C., et al. Elevations of inflammatory and procoagulant biomarkers in elderly persons with renal insufficiency. Circulation 2003, 107:87-92.
7. Chade A.R., Brosh D., Higano S.T., Lennon R.J., Lerman L.O., Lerman A. Mild renal insufficiency is associated with reduced coronary flow in patients with non-obstructive coronary artery disease. Kidney International 2006, 69:266-271.
8. Lin J., Zhu X., Chade A.R., et al. Monocyte chemoattractant proteins mediate myocardial microvascular dysfunction in swine renovascular hypertension. Arteriosclerosis, Thrombosis, and Vascular Biology 2009, 29:1810-1816.
9. Chade A.R., Zhu X., Lavi R., et al. Endothelial progenitor cells restore renal function in chronic experimental renovascular disease. Circulation 2009, 119:547-557.
10. Chade A.R., Zhu X.Y., Krier J.D., Jordan K.L., Textor S.C., Grande J.P., et al. Endothelial progenitor cells homing and renal repair in experimental renovascular disease. Stem Cells 2010, 28:1039-1047.
11. Chade A.R., Rodriguez-Porcel M., Grande J.P., et al. Distinct renal injury in early atherosclerosis and renovascular disease. Circulation 2002, 106:1165-1171.
12. Lerman L.O., Schwartz R.S., Grande J.P., Sheedy P.F., Romero J.C. Noninvasive evaluation of a novel swine model of renal artery stenosis. Journal of the American Society of Nephrology 1999, 10:1455-1465.
13. Boggia J., Li Y., Thijs L., et al. Prognostic accuracy of day versus night ambulatory blood pressure: a cohort study. Lancet 2007, 370:1219-1229.
14. Daghini E., Primak A.N., Chade A.R., et al. Evaluation of porcine myocardial microvascular permeability and fractional vascular volume using 64-slice helical computed tomography (ct). Investigative Radiology 2007, 42:274-282.
15. Rodriguez-Porcel M., Herrman J., Chade A.R., et al. Long-term antioxidant intervention improves myocardial microvascular function in experimental hypertension. Hypertension 2004, 43:493-498.
16. Zhu X.Y., Daghini E., Chade A.R., et al. Simvastatin prevents coronary microvascular remodeling in renovascular hypertensive pigs. Journal of the American Society of Nephrology 2007, 18:1209-1217.
17. Zhu X.Y., Daghini E., Chade A.R., et al. Role of oxidative stress in remodeling of the myocardial microcirculation in hypertension. Arteriosclerosis, Thrombosis, and Vascular biology 2006, 26:1746-1752.
18. Rodriguez-Porcel M., Lerman A., Herrmann J., et al. Hypertension exacerbates the effect of hypercholesterolemia on the myocardial microvasculature. Cardiovascular Research 2003, 58:213-221.
19. Zhu X.Y., Daghini E., Rodriguez-Porcel M., et al. Redox-sensitive myocardial remodeling and dysfunction in swine diet-induced experimental hypercholesterolemia. Atherosclerosis 2007, 193:62-69.
20. Zhu X.Y., Rodriguez-Porcel M., Bentley M.D., et al. Antioxidant intervention attenuates myocardial neovascularization in hypercholesterolemia. Circulation 2004, 109:2109-2115.
21. Cuocolo A., Sax F.L., Brush J.E., Maron B.J., Bacharach S.L., Bonow R.O. Left ventricular hypertrophy and impaired diastolic filling in essential hypertension. Diastolic mechanisms for systolic dysfunction during exercise. Circulation 1990, 81:978-986.
22. Valle Gottlieb M.G., da Cruz I.B., Duarte M.M., et al. Associations among metabolic syndrome, ischemia, inflammatory, oxidatives, and lipids biomarkers. The Journal of Clinical Endocrinology and Metabolism 2010, 95:586-591.
23. Suwaidi J.A., Hamasaki S., Higano S.T., Nishimura R.A., Holmes D.R., Lerman A. Long-term follow-up of patients with mild coronary artery disease and endothelial dysfunction. Circulation 2000, 101:948-954.
24. McAlister F.A., Ezekowitz J., Tonelli M., Armstrong P.W. Renal insufficiency and heart failure: prognostic and therapeutic implications from a prospective cohort study. Circulation 2004, 109:1004-1009.
25. Wali R.K., Wang G.S., Gottlieb S.S., et al. Effect of kidney transplantation on left ventricular systolic dysfunction and congestive heart failure in patients with end-stage renal disease. Journal of the American College of Cardiology 2005, 45:1051-1060.
26. London G.M., Marchais S.J., Guerin A.P., Metivier F., Adda H., Pannier B. Inflammation, arteriosclerosis, and cardiovascular therapy in hemodialysis patients. Kidney International Supplement 2003, S88-S93.
27. Ronco C., Cruz D.N., Ronco F. Cardiorenal syndromes. Current Opinion in Critical Care 2009, 15:384-391.
28. Eirin A., Zhu X.Y., Urbieta-Caceres V.H., et al. Persistent kidney dysfunction in swine renal artery stenosis correlates with outer cortical microvascular remodeling. American Journal of Physiology 2011, 300:F1394-F1401.
29. Lerman L.O., Nath K.A., Rodriguez-Porcel M., et al. Increased oxidative stress in experimental renovascular hypertension. Hypertension 2001, 37:541-546.
30. Xu J., Carretero O.A., Liao T.D., Peng H., Shesely E.G., Xu J., et al. Local angiotensin ii aggravates cardiac remodeling in hypertension. American Journal of Physiology. Heart and Circulatory Physiology 2010, 299:H1328-H1338.
31. Brown N.J. Aldosterone and end-organ damage. Current Opinion in Nephrology and Hypertension 2005, 14:235-241.
32. Barton M. Reversal of proteinuric renal disease and the emerging role of endothelin. Nature Clinical Practice 2008, 4:490-501.
33. Shigematsu Y., Hamada M., Okayama H., et al. Left ventricular hypertrophy precedes other target-organ damage in primary aldosteronism. Hypertension 1997, 29:723-727.
34. Helmersson J., Basu S. F2-isoprostane excretion rate and diurnal variation in human urine. Prostaglandins, Leukotrienes, and Essential Fatty Acids 1999, 61:203-205.
35. Bellomo G., Venanzi S., Verdura C., Saronio P., Esposito A., Timio M. Association of uric acid with change in kidney function in healthy normotensive individuals. American Journal of Kidney Diseases 2010, 56:264-272.
36. Villar A.V., Cobo M., Llano M., et al. Plasma levels of transforming growth factor-beta1 reflect left ventricular remodeling in aortic stenosis. PLoS One 2009, 4:e8476.
37. Kuwahara F., Kai H., Tokuda K., et al. Transforming growth factor-beta function blocking prevents myocardial fibrosis and diastolic dysfunction in pressure-overloaded rats. Circulation 2002, 106:130-135.
38. Sovari A.A., Dudley S.C. Using serum transforming growth factor-beta to predict myocardial fibrosis. Circulation Research 2010, 106:e3. author reply e4.
39. Melendez G.C., McLarty J.L., Levick S.P., Du Y., Janicki J.S., Brower G.L. Interleukin 6 mediates myocardial fibrosis, concentric hypertrophy, and diastolic dysfunction in rats. Hypertension 2010, 56:225-231.
40. Antonios T.F. Microvascular rarefaction in hypertension--reversal or over-correction by treatment?. American Journal of Hypertension 2006, 19:484-485.
41. Krier J.D., Rodriguez-Porcel M., Best P.J., Romero J.C., Lerman A., Lerman L.O. Vascular responses in vivo to 8-epi pgf(2alpha) in normal and hypercholesterolemic pigs. American Journal of Physiology. Regulatory, Integrative and Comparative Physiology 2002, 283:R303-R308.
42. Hoot K.E., Oka M., Han G., Bottinger E., Zhang Q., Wang X.J. Hgf upregulation contributes to angiogenesis in mice with keratinocyte-specific smad2 deletion. The Journal of Clinical Investigation 2010, 120:3606-3616.